---
type: connection
sweep_date: 2026-05-17
sweep_sha: 768d99c
section_index: 3
global_index: 3
pass3_verdict: Confirmed
overlap_tag: EXTENSION
---

# The closed-loop pharmacogenomics pipeline (genotype → production → QC → dose → biomarker) now has three canonical wiki pages forming a complete chain — the platform's personalized-medicine thesis now has an operational backbone.

3. **The closed-loop pharmacogenomics pipeline (genotype → production → QC → dose → biomarker) now has three canonical wiki pages forming a complete chain — the platform's personalized-medicine thesis now has an operational backbone.** *Supported.* `[CHAIN-DEPTH: 3+]` `[PHASE-A-MATCH: no]`

   - *Documents Connected:* `gout-action-guide.md`, `personal-genome-protocol.md`, `genotype-informed-supplement-workflow.md`, `quantification-ladder.md`, `self-experiment-protocol.md`
   - *Page-pair linkage:* `gout-action-guide.md` → `genotype-informed-supplement-workflow.md` is a **new link** (workflow page promoted 2026-05-16). `personal-genome-protocol.md` → `genotype-informed-supplement-workflow.md` is cross-referenced. `quantification-ladder.md` → `genotype-informed-supplement-workflow.md` is cross-referenced. But `gout-action-guide.md` links directly to the workflow without naming the intermediate pages; `self-experiment-protocol.md` §12 now points to the workflow page but the reverse link (workflow → self-experiment protocol) isn't prominent.
   - *Why It Matters:* The five pages compose a complete closed-loop pipeline: (1) `gout-action-guide.md` → routes the user to genotype-informed compound selection via `personal-genome-protocol.md`; (2) `personal-genome-protocol.md` → identifies variant-informed compound priorities (Q141K → butyrate emphasis; URAT1 variants → cordycepin vs eurycomanone); (3) `genotype-informed-supplement-workflow.md` → operationalizes the five-step pipeline (genotype → produce/source → Tier 2 batch QC → calibrated dose → biomarker tracking); (4) `quantification-ladder.md` → provides the Tier 1/2/3 assay framework for batch QC; (5) `self-experiment-protocol.md` → provides the biomarker tracking and red-flag halt criteria. This is a **platform-level architecture pattern** that previously existed as disconnected wiki pages — each individually rigorous but without a named path connecting them. The `gout-action-guide.md` "This year (advanced)" section now routes users through this pipeline with explicit links, but doesn't name it as a platform architecture. The pipeline is the **operational instantiation of the platform's "open-source, democratized, rigorous" thesis**: every step is documented in the wiki, achievable at home or via community biolab, and verified (genotype = clinical-grade, dose = Tier 2 QC-anchored, biomarker = self-experiment-protocol-tracked).
   - *Suggested Action:* Add a "Platform architecture — the closed-loop pharmacogenomics pipeline" subsection to `etc/open-source-platform.md` that names these five pages as a coherent pipeline and explains why the five-link chain matters for the platform's accessibility thesis. This is a strategic-positioning move, not a research finding — it makes visible something that already works but isn't named as working.

> **Pass 3 review — Confirmed.** `[OVERLAP: EXTENSION]` The five-step chain is real and already operationally named in `genotype-informed-supplement-workflow.md` as genotype → compound selection → production/source → Tier 2 batch QC → calibrated dose → biomarker tracking, with `gout-action-guide.md` routing advanced users there and `personal-genome-protocol.md`, `quantification-ladder.md`, and `self-experiment-protocol.md` supplying the upstream and downstream pieces. The proposed `etc/open-source-platform.md` addition is an architectural surfacing move, not a new science claim, and is justified because the platform page currently discusses open-source infrastructure without naming this closed-loop pharmacogenomics workflow as a platform backbone.

---

**WALKED 2026-05-19 — Closed (closed-loop pipeline named as platform architecture in `etc/open-source-platform.md`).**

Actioned:
- ✓ Added new "Operational Architecture — Closed-Loop Pharmacogenomics Pipeline" section to `wiki/etc/open-source-platform.md` (between External Service Acceleration and Platform Principles). Names the five-page chain: (1) `gout-action-guide.md` entry → (2) `personal-genome-protocol.md` variant ID → (3) `genotype-informed-supplement-workflow.md` operationalization → (4) `quantification-ladder.md` assay framework → (5) `self-experiment-protocol.md` biomarker + halt criteria. Explicitly framed as operational instantiation of Principle 3 (rigorous but accessible).
- ✓ Cross-referenced from the new section to `gout-genetic-variants.md` and the production-route SOPs as reference layers feeding into steps 1, 2, and 4.
- ✓ Explicitly framed as "architectural surfacing — naming a pattern that already operates" rather than a new scientific claim, per Pass 3's framing.
